BlackRock’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$480M Buy
21,550,921
+795,469
+4% +$19M 0.01% 1135
2025
Q4
$554M Buy
20,755,452
+486,808
+2% +$11.6M 0.01% 1026
2025
Q3
$433M Sell
20,268,644
-383,772
-2% -$9.08M 0.01% 1187
2025
Q2
$445M Sell
20,652,416
-714,141
-3% -$13.3M 0.01% 1129
2025
Q1
$355M Buy
21,366,557
+8,636,698
+68% +$157M 0.01% 1240
2024
Q4
$234M Sell
12,729,859
-64,962
-0.5% -$1.05M ﹤0.01% 1585
2024
Q3
$197M Buy
12,794,821
+732,608
+6% +$12.2M ﹤0.01% 1667
2024
Q2
$196M Buy
12,062,213
+393,473
+3% +$6.35M ﹤0.01% 1634
2024
Q1
$216M Buy
11,668,740
+258,257
+2% +$6.4M 0.01% 1600
2023
Q4
$357M Buy
11,410,483
+1,381,898
+14% +$33M 0.01% 1260
2023
Q3
$209M Sell
10,028,585
-10,916
-0.1% -$296K 0.01% 1510
2023
Q2
$240M Buy
10,039,501
+170,370
+2% +$3.79M 0.01% 1454
2023
Q1
$186M Sell
9,869,131
-390,053
-4% -$7.43M 0.01% 1593
2022
Q4
$163M Buy
10,259,184
+286,029
+3% +$4.47M 0.01% 1683
2022
Q3
$163M Buy
9,973,155
+231,841
+2% +$3.75M 0.01% 1630
2022
Q2
$137M Sell
9,741,314
-228,709
-2% -$4.27M ﹤0.01% 1816
2022
Q1
$241M Sell
9,970,023
-90,289
-0.9% -$2.18M 0.01% 1524
2021
Q4
$235M Sell
10,060,312
-94,639
-0.9% -$1.9M 0.01% 1613
2021
Q3
$169M Buy
10,154,951
+15,748
+0.2% +$304K ﹤0.01% 1848
2021
Q2
$247M Buy
10,139,203
+2,737,601
+37% +$61.8M 0.01% 1614
2021
Q1
$191M Buy
7,401,602
+170,805
+2% +$7.52M 0.01% 1770
2020
Q4
$387M Buy
7,230,797
+69,586
+1% +$3.45M 0.01% 1086
2020
Q3
$295M Sell
7,161,211
-596,635
-8% -$25.8M 0.01% 1083
2020
Q2
$376M Sell
7,757,846
-2,378,264
-23% -$114M 0.02% 891
2020
Q1
$428M Sell
10,136,110
-102,785
-1% -$4.24M 0.02% 692
2019
Q4
$438M Buy
10,238,895
+709,570
+7% +$30.9M 0.02% 893
2019
Q3
$343M Sell
9,529,325
-124,239
-1% -$3.77M 0.01% 1018
2019
Q2
$258M Sell
9,653,564
-1,065,144
-10% -$27.2M 0.01% 1237
2019
Q1
$288M Buy
10,718,708
+585,242
+6% +$13.7M 0.01% 1141
2018
Q4
$164M Buy
10,133,466
+346,561
+4% +$6.73M 0.01% 1456
2018
Q3
$203M Buy
9,786,905
+51,804
+0.5% +$815K 0.01% 1491
2018
Q2
$149M Buy
9,735,101
+3,085,874
+46% +$55M 0.01% 1660
2018
Q1
$149M Sell
6,649,227
-61,470
-0.9% -$1.7M 0.01% 1567
2017
Q4
$202M Buy
6,710,697
+321,950
+5% +$10.3M 0.01% 1367
2017
Q3
$241M Buy
6,388,747
+798,041
+14% +$26M 0.01% 1191
2017
Q2
$156M Buy
5,590,706
+157,497
+3% +$4.69M 0.01% 1488
2017
Q1
$187M Buy
5,433,209
+5,334,832
+5,423% +$188M 0.01% 1349
2016
Q4
$2.84M Buy
98,377
+84,906
+630% +$2.25M ﹤0.01% 1093
2016
Q3
$428K Buy
13,471
+1,094
+9% +$37.1K ﹤0.01% 1798
2016
Q2
$401K Buy
12,377
+6,963
+129% +$233K ﹤0.01% 1758
2016
Q1
$152K Buy
5,414
+3,153
+139% +$68.8K ﹤0.01% 1814
2015
Q4
$81K Buy
2,261
+542
+32% +$19.1K ﹤0.01% 1836
2015
Q3
$57K Sell
1,719
-337
-16% -$14K ﹤0.01% 1862
2015
Q2
$86K Sell
2,056
-22
-1% -$851 ﹤0.01% 1835
2015
Q1
$68K Hold
2,078
﹤0.01% 1853
2014
Q4
$66K Sell
2,078
-330
-14% -$9.36K ﹤0.01% 1846
2014
Q3
$60K Hold
2,408
﹤0.01% 1847
2014
Q2
$55K Sell
2,408
-103
-4% -$2.15K ﹤0.01% 1896
2014
Q1
$61K Buy
2,511
+147
+6% +$3.72K ﹤0.01% 1829
2013
Q4
$59K Hold
2,364
﹤0.01% 1877
2013
Q3
$65K Sell
2,364
-40,877
-95% -$855K ﹤0.01% 1762
2013
Q2
$784K Buy
+43,241
New +$596K ﹤0.01% 1109

Other funds holding ACAD